Strados Labs is on a mission to enhance the quality of life for individuals living with chronic respiratory diseases, such as asthma and COPD, which impact over 300 million people globally. Their groundbreaking RESP® Biosensor continuously captures vital lung sounds—including coughs, wheezes, and crackles—providing crucial insights into patient respiratory health from the comfort of home. Leveraging advanced technology, this device not only tracks symptoms in relation to treatment but also helps prevent unnecessary hospitalizations by identifying exacerbations early.

Founded by Nick Delmonico, who personally experienced the challenges of managing asthma, Strados Labs emerged from a health hackathon in 2016. The company focuses on improving communication between patients and clinicians through innovative wearables and a proprietary cloud platform that processes extensive lung sound data—over 100,000 validated events! With FDA clearance and a commitment to patient comfort and privacy, Strados Labs actively supports both healthcare systems and life sciences in their efforts to better manage respiratory conditions while empowering patients every step of the way.